|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss attributable to common stockholders | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Loss on disposal of equipment | |||||
| Net gain on disposal of assets | |||||
| Stock-based compensation expense | |||||
| Amortization of operating lease right-of-use assets | |||||
| Amortization of finance lease right-of-use assets | |||||
| Amortization of bond premium | |||||
| Change in fair value of warrant liability | |||||
| Impairment charges of goodwill and other intangible assets | |||||
| Impairment charges of other assets | |||||
| Income tax benefit | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of assets | |||||
| Purchases of marketable debt securities | |||||
| Proceeds from sales of marketable debt securities | |||||
| Purchases of leasehold improvements and equipment | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Gross proceeds from private placement of preferred stock and common stock warrants | |||||
| Transaction costs paid pursuant to private placement | |||||
| Net proceeds from exercise of warrants | |||||
| Net proceeds from public offerings of common stock and warrants | |||||
| Payments of capital lease liability – principal | |||||
| Net cash provided by financing activities | |||||
| Net (decrease)/increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental non-cash financing and investing activities: | |||||
| Reclassification of warrants from liability to equity | |||||
| Unrealized gain on marketable debt securities | |||||
| Exchange of warrants for shares of common stock | |||||
| Reduction of right-of-use assets and lease liabilities on lease termination | |||||
Loading...